Prikaz osnovnih podataka o dokumentu

dc.creatorVučković, Nemanja
dc.creatorPrlainović, Nevena
dc.creatorGlođović, Nikola
dc.creatorČalija, Bojan
dc.creatorMilosavljević, Nedeljko
dc.creatorKalagasidis Krušić, Melina
dc.creatorMilašinović, Nikola
dc.date.accessioned2024-01-26T11:17:42Z
dc.date.available2024-01-26T11:17:42Z
dc.date.issued2024
dc.identifier.issn1735-207X
dc.identifier.urihttp://TechnoRep.tmf.bg.ac.rs/handle/123456789/7149
dc.description.abstractNovel polymer network microformulations have been widely used for pharmaceutical applications. Especially challenging is to design and develop an ideal oral drug formulation due to many hostile factors in gastrointestinal (GI) tract microenvironment. Hydrogels attained striking attention for the use in controlled drug delivery systems, and for that purpose temperature- and pH-sensitive hydrogels have been extensively employed. This paper reports synthesis and characterization of innovative polymers-crosslinked hydrogel system consisted of N-isopropylacrylamide-graft-dextran (NiPAAm-g-Dex) and chitosan (Ch). Composition of the system was optimized to demonstrate distinguished encapsulation efficiency (EE) and release properties of diclofenac sodium (DS). The microspheres structure and morphology were confirmed by attenuated total reflectance Fourier transform infrared spectroscopy (ATR FT-IR) and scanning electron microscopy (SEM), respectively. Prepared microparticles have successfully passed through the simulated gastric and small intestine and reached the intestine, where the release of DS was carried out. In vitro release studies showed smooth release profile in a controllable manner with up to 40% release of the model drug after 4 h at pH 7.20 ± 0.01. Based on the results, novel polymer microformulations show excellent potential as controlled release drug delivery system and represent a superb candidate for additional in vivo testing.
dc.publisherSpringer Science and Business Media Deutschland GmbH
dc.relationinfo:eu-repo/grantAgreement/MESTD/inst-2020/200115/RS//
dc.relationinfo:eu-repo/grantAgreement/MESTD/inst-2020/200135/RS//
dc.rightsrestrictedAccess
dc.sourceJournal of the Iranian Chemical Society
dc.subjectChitosan
dc.subjectDextran
dc.subjectDiclofenac sodium
dc.subjectInverse emulsion method
dc.subjectMicroformulations
dc.subjectN-isopropylacrylamide
dc.titleNovel chitosan and N-isopropylacrylamide-grafted-dextran-based microformulations as effective oral drug delivery system
dc.typearticle
dc.rights.licenseARR
dc.identifier.doi10.1007/s13738-023-02960-1
dc.identifier.scopus2-s2.0-85182432691
dc.type.versionpublishedVersion


Dokumenti

Thumbnail

Ovaj dokument se pojavljuje u sledećim kolekcijama

Prikaz osnovnih podataka o dokumentu